269 related articles for article (PubMed ID: 27688436)
21. Periorbital hyperpigmentation: review of etiology, medical evaluation, and aesthetic treatment.
Roberts WE
J Drugs Dermatol; 2014 Apr; 13(4):472-82. PubMed ID: 24719068
[TBL] [Abstract][Full Text] [Related]
22. Postinflammatory hyperpigmentation secondary to external insult: an overview of the quantitative analysis of pigmentation.
Lamel SA; Rahvar M; Maibach HI
Cutan Ocul Toxicol; 2013 Mar; 32(1):67-71. PubMed ID: 22667459
[TBL] [Abstract][Full Text] [Related]
23. Clinical efficacy and safety of a multimodality skin brightener composition compared with 4% hydroquinone.
Makino ET; Mehta RC; Garruto J; Gotz V; Sigler ML; Herndon JH
J Drugs Dermatol; 2013 Mar; 12(3):s21-6. PubMed ID: 23545929
[TBL] [Abstract][Full Text] [Related]
24. New and emerging treatments for hyperpigmentation.
Alexis AF
J Drugs Dermatol; 2014 Apr; 13(4):382-5. PubMed ID: 24719055
[TBL] [Abstract][Full Text] [Related]
25. Skin complexion and pigmentary disorders in facial skin of 1204 women in 4 Indian cities.
Hourblin V; Nouveau S; Roy N; de Lacharrière O
Indian J Dermatol Venereol Leprol; 2014; 80(5):395-401. PubMed ID: 25201838
[TBL] [Abstract][Full Text] [Related]
26. A microsponge formulation of hydroquinone 4% and retinol 0.15% in the treatment of melasma and postinflammatory hyperpigmentation.
Grimes PE
Cutis; 2004 Dec; 74(6):362-8. PubMed ID: 15663072
[TBL] [Abstract][Full Text] [Related]
27. Hyperpigmentation and melasma.
Rigopoulos D; Gregoriou S; Katsambas A
J Cosmet Dermatol; 2007 Sep; 6(3):195-202. PubMed ID: 17760699
[TBL] [Abstract][Full Text] [Related]
28. Management of hyperpigmentation in darker racial ethnic groups.
Grimes PE
Semin Cutan Med Surg; 2009 Jun; 28(2):77-85. PubMed ID: 19608057
[TBL] [Abstract][Full Text] [Related]
29. Increasing our understanding of pigmentary disorders.
Grimes P; Nordlund JJ; Pandya AG; Taylor S; Rendon M; Ortonne JP
J Am Acad Dermatol; 2006 May; 54(5 Suppl 2):S255-61. PubMed ID: 16631966
[TBL] [Abstract][Full Text] [Related]
30. Clinical efficacy and safety of a multimodality skin brightener composition compared with 4% hydroquinone.
Makino ET; Herndon JH; Sigler ML; Gotz V; Garruto J; Mehta RC
J Drugs Dermatol; 2012 Dec; 11(12):1478-82. PubMed ID: 23377519
[TBL] [Abstract][Full Text] [Related]
31. Widespread use of toxic skin lightening compounds: medical and psychosocial aspects.
Ladizinski B; Mistry N; Kundu RV
Dermatol Clin; 2011 Jan; 29(1):111-23. PubMed ID: 21095535
[TBL] [Abstract][Full Text] [Related]
32. Pigmentation disorders: hyperpigmentation and hypopigmentation.
Nicolaidou E; Katsambas AD
Clin Dermatol; 2014; 32(1):66-72. PubMed ID: 24314378
[TBL] [Abstract][Full Text] [Related]
33. Recent progress in melasma pathogenesis.
Lee AY
Pigment Cell Melanoma Res; 2015 Nov; 28(6):648-60. PubMed ID: 26230865
[TBL] [Abstract][Full Text] [Related]
34. A promising new treatment for solar lentigines.
Colby SI; Schwartzel EH; Huber FJ; Highton A; Altman DJ; Epinette WW; Lyon E
J Drugs Dermatol; 2003 Apr; 2(2):147-52. PubMed ID: 12852366
[TBL] [Abstract][Full Text] [Related]
35. Common disorders of pigmentation: when are more than cosmetic cover-ups required?
Hacker SM
Postgrad Med; 1996 Jun; 99(6):177-86. PubMed ID: 8668630
[TBL] [Abstract][Full Text] [Related]
36. Treatment of hyperpigmentation.
Rossi AM; Perez MI
Facial Plast Surg Clin North Am; 2011 May; 19(2):313-24. PubMed ID: 21763992
[TBL] [Abstract][Full Text] [Related]
37. Latest insights into skin hyperpigmentation.
Ortonne JP; Bissett DL
J Investig Dermatol Symp Proc; 2008 Apr; 13(1):10-4. PubMed ID: 18369333
[TBL] [Abstract][Full Text] [Related]
38. [Considerations on photoprotection and skin disorders].
Cestari TF; de Oliveira FB; Boza JC
Ann Dermatol Venereol; 2012 Nov; 139 Suppl 3():S83-91. PubMed ID: 23260523
[TBL] [Abstract][Full Text] [Related]
39. Natural products as photoprotection.
Saewan N; Jimtaisong A
J Cosmet Dermatol; 2015 Mar; 14(1):47-63. PubMed ID: 25582033
[TBL] [Abstract][Full Text] [Related]
40. 4-n-butylresorcinol, a highly effective tyrosinase inhibitor for the topical treatment of hyperpigmentation.
Kolbe L; Mann T; Gerwat W; Batzer J; Ahlheit S; Scherner C; Wenck H; Stäb F
J Eur Acad Dermatol Venereol; 2013 Jan; 27 Suppl 1():19-23. PubMed ID: 23205541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
